Over the years before the Covid-19 pandemic hit the world, most clinical trials and clinical research were based on a centralized system which proved to be working until the pandemic hit, and it all changed. So, to adjust to the evolving reality after the Covid-19 pandemic, the clinical trials market had to adopt a decentralized trials system to conduct clinical research more effectively and efficiently.

The switch to decentralized trials has proven to be very beneficial to all parties involved. This includes everyone from the patient to the research groups responsible for data collection and those running the clinical studies. Therefore, in this post, you’ll learn what a Decentralized Clinical Trial Trend is, its benefits, and some of the trends in decentralized trials.

What is a Decentralized Clinical Trial?

In a decentralized clinical trial, the party conducting the investigation and collecting the data applies several clinical techniques during the trial. With decentralized trials, the research sites are also scattered across the study area; thus, patients don’t always have to travel to the doctor, but the doctor/researcher can come to the patient.

One thing about decentralized systems is that they exist on a spectrum. This allows the individuals running the clinical studies a wide range of options on how to conduct the study. As a result, it offers room for virtual trials where the patient can perform the trial alone but under the guidance of the researcher.

That flexibility, however, doesn’t exist in a regulatory vacuum. The FDA has developed a clear framework outlining how decentralized trials should be structured, documented, and overseen to ensure participant safety and data integrity. Understanding FDA guidance on decentralized trial regulations is essential for sponsors and investigators who want to take full advantage of remote and hybrid study designs without running afoul of compliance requirements. These guidelines directly shape which technologies and data collection methods are considered acceptable—setting the stage for the role that wearables and other digital tools now play in modern trial execution.

Also, with decentralized trials, data quality, and data collection can be improved by using new technologies like wearable devices that keep track of the patient’s behavior and responses to the clinical trial and relay the information directly to the pharmaceutical companies or research sites.

Benefits Of Decentralized Clinical Trials

Accelerating patient recruitment

Since the decentralized trials tend to use digital health technologies, which most patients view as easy to use thus, more are willing to join. Also, they help reduce the number of hospital and research sites visits for the patients

Improved data collection and quality

Since most decentralized trials use the latest technologies like wearable devices and apps, the data collection process is more efficient. The data is way more accurate than traditional data collection methods. Also, the data quality is very high, given that it is collected from a real-world setting

More patient involvement

With the implementation of artificial intelligence into most decentralized clinical trial programs, patients become more involved and engaged. They can, at times, run the tests alone and enter the findings into clinical solutions availed to them like an electronic diary which the researcher can access

Improved participant diversity

With decentralized clinical research, you are assured of a much more diverse participant pool which is a must condition for most clinical trial regulatory agencies, especially if you are specializing in drug development

What Are the Latest Decentralized Clinical Trial Trends in The Market

Ever since the Covid-19 pandemic, many health sector members, including pharmaceutical companies, have been aiming at developing new trends that will give them an edge in the fight for a larger market share in clinical studies. Some of these recent trends include:

The continued growth of decentralized clinical studies

Due to the Covid-19 pandemic, most clinical studies have been altered to accommodate a decentralized system, mainly because there are so many benefits to pharmaceutical companies or research groups under a decentralized system.

Increased participation in clinical trials

Most individuals fear being part of clinical research trials mainly because they aren’t aware of what it entails. They aren’t aware of the distance to the research sites, and the lack of any control over the trial. But with decentralized clinical trials, the research sites are close to the participants.

Also, participants have a semblance of control, especially in virtual trials. This is because they can conduct the trial alone under the guidance of the researchers and then feed in the results virtually

Improved data quality and accuracy

Since decentralized trials mainly utilize digital health technologies such as wearable devices, data collection accuracy is much increased. Also, with wearable devices, data is more valuable since it is collected in real time and in a much more natural setting

Improved patient recruitment

With the implementation of artificial intelligence in patient requirements for decentralized trials, the recruitment process continues to be more streamlined, efficient, and fast. Mainly because artificial intelligence is responsible for filtering the potential candidates as per the set rules and guidelines of the clinical trial.